By Staff Reporter
The Gates Foundation has announced a record US$2.5 billion commitment through 2030 to fund research and development (R&D) in women’s health, one of the largest single investments in the sector.
The initiative aims to fast-track over 40 innovations in five critically underfunded areas, focusing especially on women in low- and middle-income countries.
Join our WhatsApp Channel
For too long, women have suffered from health conditions that are misunderstood, misdiagnosed, or ignored,” said Dr. Anita Zaidi, president of the foundation’s Gender Equality Division. “We want this investment to spark a new era of women-centered innovation, one where women’s lives, bodies, and voices are prioritized in health R&D.”
The targeted areas include gynecological and menstrual health, obstetric care, contraceptive innovation, sexually transmitted infection (STI) solutions such as HIV pre-exposure prophylaxis (PrEP), and maternal health and nutrition. These fields receive only a fraction of global R&D funding. A 2021 McKinsey & Company analysis found that just 1percent of healthcare research focuses on female-specific conditions outside of cancer.
“This is the largest investment we’ve ever made in women’s health research and development, but it still falls far short of what is needed in a neglected and underfunded area of huge human need and opportunity,” said Zaidi.
The foundation’s funding will support the development of tools like non-hormonal contraceptives, therapeutics for preeclampsia, and research into the vaginal microbiome. In addition, it will back data generation and advocacy efforts to boost uptake of new treatments once approved.
“This commitment brings much-needed attention to the health challenges women face in places where resources are most limited and the burden is highest,” said Dr. Bosede Afolabi, a professor of obstetrics and gynecology at the University of Lagos. “It reflects a recognition that women’s lives, and the innovations that support them must be prioritized everywhere.”
The Gates Foundation is calling on governments, philanthropists, investors, and private companies to co-invest in these areas, helping to shape the development and delivery of women’s health solutions.
“Investing in women’s health has a lasting impact across generations. It leads to healthier families, stronger economies, and a more just world,” said Bill Gates, chair of the foundation. “Yet women’s health continues to be ignored, underfunded, and sidelined. Too many women still die from preventable causes or live in poor health. That must change.”
The foundation emphasized that the selected priority areas were chosen based on where innovation can have the most life-saving impact, informed by both scientific evidence and the lived experiences of women globally. They also address the specific challenges of low-resource settings, where healthcare systems face the greatest strain.
According to the foundation, closing the gender health gap could yield up to US$1 trillion in economic growth annually by 2040. Every US$1 invested in women’s health is estimated to generate US$3 in economic return.
This latest move builds on the Gates Foundation’s 25-year history in advancing maternal and child health, promoting the HPV vaccine, scaling up women’s health commodities, and supporting women’s empowerment initiatives. It also aligns with its broader goals through 2045 to reduce preventable deaths, end deadly infectious diseases, and lift millions out of poverty.
